Cargando…

Evaluation of a (68)Ga-Labeled DOTA-Tetrazine as a PET Alternative to (111)In-SPECT Pretargeted Imaging

The bioorthogonal reaction between a tetrazine and strained trans-cyclooctene (TCO) has garnered success in pretargeted imaging. This reaction was first validated in nuclear imaging using an (111)In-labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-linked bispyridyl tetrazine (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Edem, Patricia E., Jørgensen, Jesper T., Nørregaard, Kamilla, Rossin, Rafaella, Yazdani, Abdolreza, Valliant, John F., Robillard, Marc, Herth, Matthias M., Kjaer, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036891/ https://www.ncbi.nlm.nih.gov/pubmed/31979070 http://dx.doi.org/10.3390/molecules25030463

Ejemplares similares

Evaluation of the inverse electron demand Diels-Alder reaction in rats using a scandium-44-labelled tetrazine for pretargeted PET imaging
por: Edem, Patricia E., et al.
Publicado: (2019)

Trans-Cyclooctene-Functionalized PeptoBrushes with Improved Reaction Kinetics of the Tetrazine Ligation for Pretargeted Nuclear Imaging
por: Stéen, E. Johanna L., et al.
Publicado: (2019)

Lipophilicity and Click Reactivity Determine the Performance of Bioorthogonal Tetrazine Tools in Pretargeted In Vivo Chemistry
por: Stéen, E. Johanna L., et al.
Publicado: (2021)

Development of (18)F-Labeled Bispyridyl Tetrazines for In Vivo Pretargeted PET Imaging
por: García-Vázquez, Rocío, et al.
Publicado: (2022)

Evaluation of [(64)Cu]Cu-NOTA-PEG(7)-H-Tz for Pretargeted Imaging in LS174T Xenografts—Comparison to [(111)In]In-DOTA-PEG(11)-BisPy-Tz
por: Poulie, Christian B. M., et al.
Publicado: (2021)

Recent Advances in the Development of Tetrazine Ligation Tools for Pretargeted Nuclear Imaging
por: García-Vázquez, Rocío, et al.
Publicado: (2022)

Direct Cu-mediated aromatic (18)F-labeling of highly reactive tetrazines for pretargeted bioorthogonal PET imaging
por: García-Vázquez, Rocío, et al.
Publicado: (2021)

Pretargeted Imaging with Gallium-68—Improving the Binding Capability by Increasing the Number of Tetrazine Motifs
por: Summer, Dominik, et al.
Publicado: (2018)

Tetrazine Carbon Nanotubes for Pretargeted In Vivo “Click‐to‐Release” Bioorthogonal Tumour Imaging
por: Li, He, et al.
Publicado: (2020)

Cost-Effectiveness Analysis of (68)Ga DOTA-TATE PET/CT, (111)In-Pentetreotide SPECT/CT and CT for Diagnostic Workup of Neuroendocrine Tumors
por: Froelich, Matthias Frank, et al.
Publicado: (2021)

Pretargeting of internalizing trastuzumab and cetuximab with a (18)F-tetrazine tracer in xenograft models
por: Keinänen, Outi, et al.
Publicado: (2017)

Clearing and Masking Agents in Pretargeting Strategies
por: Staudt, Markus, et al.
Publicado: (2023)

Antibody PEGylation in bioorthogonal pretargeting with trans-cyclooctene/tetrazine cycloaddition: in vitro and in vivo evaluation in colorectal cancer models
por: Rondon, Aurélie, et al.
Publicado: (2017)

Synthesis and radiolabeling of a polar [(125)I]I‐1,2,4,5‐tetrazine
por: Bidesi, Natasha, et al.
Publicado: (2022)

(18)F-FDG positron emission tomography and diffusion-weighted magnetic resonance imaging for response evaluation of nanoparticle-mediated photothermal therapy
por: Simón, Marina, et al.
Publicado: (2020)

Site-specific conjugation allows modulation of click reaction stoichiometry for pretargeted SPECT imaging
por: Mandikian, Danielle, et al.
Publicado: (2018)

Manipulating the In Vivo Behaviour of (68)Ga with Tris(Hydroxypyridinone) Chelators: Pretargeting and Blood Clearance
por: Imberti, Cinzia, et al.
Publicado: (2020)

Preparation and Biological Study of (68)Ga-DOTA-alendronate
por: Fakhari, Ashraf, et al.
Publicado: (2016)

Pretargeted Imaging and Radioimmunotherapy of Cancer Using Antibodies and Bioorthogonal Chemistry
por: van de Watering, Floor C. J., et al.
Publicado: (2014)

Fractionated photothermal therapy in a murine tumor model: comparison with single dose
por: Simón, Marina, et al.
Publicado: (2019)

Development of the First Tritiated Tetrazine: Facilitating Tritiation of Proteins
por: Radjani Bidesi, Natasha Shalina, et al.
Publicado: (2022)

Pretargeted imaging beyond the blood–brain barrier
por: Shalgunov, Vladimir, et al.
Publicado: (2022)

SPECT/NIRF Dual Modality Imaging for Detection of Intraperitoneal Colon Tumor with an Avidin/Biotin Pretargeting System
por: Dong, Chengyan, et al.
Publicado: (2016)

Optimization of Direct Aromatic (18)F-Labeling of Tetrazines
por: Andersen, Ida Vang, et al.
Publicado: (2022)

Non-invasive Early Response Monitoring of Nanoparticle-assisted Photothermal Cancer Therapy Using (18)F-FDG, (18)F-FLT, and (18)F-FET PET/CT Imaging
por: Jørgensen, Jesper Tranekjær, et al.
Publicado: (2018)

Physiological Biodistribution of (68)Ga-DOTA-TATE in Normal Subjects
por: Özgüven, Salih, et al.
Publicado: (2021)

Initial Clinical Experience with (68)Ga-DOTA-NOC Prepared Using (68)Ga from Nanoceria-polyacrylonitrile Composite Sorbent-based (68)Ge/(68)Ga Generator and Freeze-dried DOTA-NOC Kits
por: Chandra, Piyush, et al.
Publicado: (2017)

Pretargeted Imaging beyond the Blood–Brain Barrier—Utopia or Feasible?
por: Lopes van den Broek, Sara, et al.
Publicado: (2022)

Therapeutic Applications of Pretargeting
por: Verhoeven, Marjolein, et al.
Publicado: (2019)

Highly variable biodistribution of (68)Ga labeled somatostatin analogues (68)Ga-DOTA-NOC and (68)Ga-DOTA-TATE in neuroendocrine tumors: clinical implications for somatostatin receptor directed PET/CT
por: Cheng, Monica, et al.
Publicado: (2022)

Head-to-Head Comparison of (68)Ga-DOTA-TATE and (68)Ga-DOTA-JR11 PET/CT in Patients With Tumor-Induced Osteomalacia: A Prospective Study
por: Hou, Guozhu, et al.
Publicado: (2022)

Radiolabeled albumin through S(N)Ar of cysteines as a potential pretargeting theranostic agent
por: Fischer, Niklas H., et al.
Publicado: (2022)

Antibody-Based In Vivo Imaging of Central Nervous System Targets—Evaluation of a Pretargeting Approach Utilizing a TCO-Conjugated Brain Shuttle Antibody and Radiolabeled Tetrazines
por: Bredack, Christoph, et al.
Publicado: (2022)

Development of (111)In-labeled porphyrins for SPECT imaging
por: Sadeghi, Shaghayegh, et al.
Publicado: (2014)

Standardized image quality for (68)Ga-DOTA-TATE PET/CT
por: Cox, Christina P. W., et al.
Publicado: (2020)

[(68)Ga]Ga-DOTA-TOC: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging
por: Hennrich, Ute, et al.
Publicado: (2020)

111In-Octreoscan SPECT/CT hybrid imaging and 68Ga-DOTANOC PET/CT in neuroendocrine adenoma of the middle ear (NAME)
por: Pontico, Mariano, et al.
Publicado: (2020)

Relationships between uptake of [(68)Ga]Ga-DOTA-TATE and absorbed dose in [(177)Lu]Lu-DOTA-TATE therapy
por: Stenvall, Anna, et al.
Publicado: (2022)

Correlations between [(68)Ga]Ga-DOTA-TOC Uptake and Absorbed Dose from [(177)Lu]Lu-DOTA-TATE
por: Bruvoll, Ragnar, et al.
Publicado: (2023)

Single Particle and PET-based Platform for Identifying Optimal Plasmonic Nano-Heaters for Photothermal Cancer Therapy
por: Jørgensen, Jesper Tranekjær, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_d9hk6u5hv3ojt5l1cqpns6jgf8